Figure 4.
OS. (A) Survival from diagnosis of the whole cohort (259 patients, median 99 months). (B) Survival from the time of initiation of second-line therapy (92 patients, median 59 months).
OS. (A) Survival from diagnosis of the whole cohort (259 patients, median 99 months). (B) Survival from the time of initiation of second-line therapy (92 patients, median 59 months).
